» Articles » PMID: 25562267

Association Between Bariatric Surgery and Long-term Survival

Overview
Journal JAMA
Specialty General Medicine
Date 2015 Jan 7
PMID 25562267
Citations 188
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Accumulating evidence suggests that bariatric surgery improves survival among patients with severe obesity, but research among veterans has shown no evidence of benefit.

Objective: To examine long-term survival in a large multisite cohort of patients who underwent bariatric surgery compared with matched control patients.

Design, Setting, And Participants: In a retrospective cohort study, we identified 2500 patients (74% men) who underwent bariatric surgery in Veterans Affairs (VA) bariatric centers from 2000-2011 and matched them to 7462 control patients using sequential stratification and an algorithm that included age, sex, geographic region, body mass index, diabetes, and Diagnostic Cost Group. Survival was compared across patients who underwent bariatric surgery and matched controls using Kaplan-Meier estimators and stratified, adjusted Cox regression analyses.

Exposures: Bariatric procedures, which included 74% gastric bypass, 15% sleeve gastrectomy, 10% adjustable gastric banding, and 1% other.

Main Outcomes And Measures: All-cause mortality through December 2013.

Results: Surgical patients (n = 2500) had a mean age of 52 years and a mean BMI of 47. Matched control patients (n = 7462) had a mean age of 53 years and a mean BMI of 46. At the end of the 14-year study period, there were a total of 263 deaths in the surgical group (mean follow-up, 6.9 years) and 1277 deaths in the matched control group (mean follow-up, 6.6 years). Kaplan-Meier estimated mortality rates were 2.4% at 1 year, 6.4% at 5 years, and 13.8% at 10 years for surgical patients; for matched control patients, 1.7% at 1 year, 10.4% at 5 years, and 23.9% at 10 years. Adjusted analysis showed no significant association between bariatric surgery and all-cause mortality in the first year of follow-up (adjusted hazard ratio [HR], 1.28 [95% CI, 0.98-1.68]), but significantly lower mortality after 1 to 5 years (HR, 0.45 [95% CI, 0.36-0.56]) and 5 to 14 years (HR, 0.47 [95% CI, 0.39-0.58]). The midterm (>1-5 years) and long-term (>5 years) relationships between surgery and survival were not significantly different across subgroups defined by diabetes diagnosis, sex, and period of surgery.

Conclusions And Relevance: Among obese patients receiving care in the VA health system, those who underwent bariatric surgery compared with matched control patients who did not have surgery had lower all-cause mortality at 5 years and up to 10 years following the procedure. These results provide further evidence for the beneficial relationship between surgery and survival that has been demonstrated in younger, predominantly female populations.

Citing Articles

Utilization of Low-Dose Phentermine for Weight Loss Prior to Metabolic and Bariatric Surgery: A Prospective, Randomized, and Placebo-Controlled Trial.

Garcia L, Rivas H, Morton J Obes Sci Pract. 2025; 11(1):e70043.

PMID: 39830713 PMC: 11739713. DOI: 10.1002/osp4.70043.


8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S167-S180.

PMID: 39651976 PMC: 11635032. DOI: 10.2337/dc25-S008.


The Efficacy and Adverse Effects of Sugammadex and Neostigmine in Reversing Neuromuscular Blockade Inpatients with Obesity Undergoing Metabolic and Bariatric Surgery: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.

Wang S, Dong Y, Wang S, Han Y, Li Q Medicina (Kaunas). 2024; 60(11).

PMID: 39597027 PMC: 11596585. DOI: 10.3390/medicina60111842.


A comparison of time-varying propensity score vs sequential stratification approaches to longitudinal matching with a time-varying treatment.

Richey M, Maciejewski M, Zepel L, Arterburn D, Kawatkar A, Sloan C BMC Med Res Methodol. 2024; 24(1):280.

PMID: 39538155 PMC: 11562661. DOI: 10.1186/s12874-024-02391-3.


Fat Mass Index Predicts the Effect of Weight Loss and Quality of Life Early After Laparoscopic Sleeve Gastrectomy.

Jiang Y, Zhong Q, Shang-Guan Z, Lin G, Guo X, Huang Z Obes Surg. 2024; 34(11):4125-4135.

PMID: 39340581 DOI: 10.1007/s11695-024-07518-5.